INAVA and inflammatory bowel disease: As pro-inflammatory cytokines are increased in IBD patients(30), these results suggest that the decrease in C1ORF106 expression in susceptible individuals could increase ROCK activity and make them more sensitive to pro-inflammatory cytokines.